HaystackAnalytics
haystackanalytics.in
As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
HaystackAnalytics builds genomics diagnostics that use sequencing and machine learning to identify pathogens and drug resistance. Founded in 2019 as an IIT Bombay spin-out, its tuberculosis and infection panels return results far faster than culture. The company operates its own accredited laboratory in Mumbai.
News
HaystackAnalytics uses advanced genomics to bridge diagnostic gap in infectious diseases
Instead of relying exclusively on specialized centers far from patients and using only traditional diagnostic methods, hospitals would be able to use advanced sequencing closer to the diagnostic centers and would be able to study complex infections closer
Read more
Report
HaystackAnalytics gets NABL-accreditation for clinical genomics meeting international standards for quality, reliability
HaystackAnalytics gets NABL-accreditation for clinical genomics meeting international standards for quality, reliability
Read more
Report
HaystackAnalytics obtains NABL accreditation
Genomics-based Diagnostics: The nodal body has accredited HaystackAnalytics' human genomics tests under whole exome sequencing (WES) and pharmacogenomics (PGx).
Read more
Report
HaystackAnalytics expands infexn Test for infectious diseases
Infexn Test: By analyzing respiratory samples such as VTM and BAL, the expanded infexn - NGS test offers clinicians a more streamlined approach to diagnosing infections, enabling them to screen for major RNA viruses, bacterial and fungal pathogens, and AM
Read more
Report
HaystackAnalytics: Ushering in the genomic revolution Unusual Suspects- Moneycontrol.com
In this episode, CEO of HaystackAnalytics Anirvan Chatterjee and co-founder Gaurav Srivastava talk about building state of the art genomics solutions for accurate, personalized clinical decisions. As India continues to bear the largest share of TB cases i
Read more
Report
Pro access
Upgrade to see all 10 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.